Managers / Q4 2024
Corbin Capital Partners, L.P.
CIK 0001509874 · 575 MADISON AVENUE, 21ST FLOOR, NEW YORK, NY, 10022 · 212-634-7373
Summary
Corbin Capital Partners, L.P. reported $61M in U.S.-listed holdings across 27 positions for Q4 2024.
The portfolio is heavily concentrated: Endeavor alone accounts for 46.9% of reported value.
Compared with Q3 2024, the fund opened 2 new positions and exited 5.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 64.4% · $39M
- ETP · 33.2% · $20M
- Equity WRT · 1.5% · $948,012
- Other · 0.6% · $364,297
- PUBLIC · 0.2% · $152,500
Quarter-over-Quarter Changes full breakdown →
vs Q3 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| NVTSNAVITAS SEMICONDUCTOR CORP | NEW | +216.5K | 216.5K | +$772,959 | $772,959 |
| WHEELER REAL ESTATE INVT TR | NEW | +50.0K | 50.0K | +$152,500 | $152,500 |
| SRGSERITAGE GROWTH PPTYS | SOLD OUT | −214.2K | 0 | −$996,118 | $0 |
| SOLENO THERAPEUTICS INC | SOLD OUT | −11.7K | 0 | −$589,976 | $0 |
| HIPOHIPPO HLDGS INC | SOLD OUT | −24.0K | 0 | −$405,120 | $0 |
| TERRAN ORBITAL CORPORATION | SOLD OUT | −256.6K | 0 | −$64,455 | $0 |
| COMPASS DIGITAL ACQUISITN CO | SOLD OUT | −61.2K | 0 | −$3,732 | $0 |
| ROIVROIVANT SCIENCES LTD | TRIMMED | −104.2K | 46.6K | −$1M | $551,763 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ENDEAVOR GROUP HLDGS INC | CL A COM | 46.92% | $29M | 918.5K |
| 2 | ISHARES TR | IBOXX HI YD ETF | 16.64% | $10M | 129.6K |
| 3 | BKLNINVESCO EXCH TRADED FD TR IIhistory → | SR LN ETF | 16.60% | $10M | 482.5K |
| 4 | CORZCORE SCIENTIFIC INC NEWhistory → | COM | 9.22% | $6M | 402.0K |
| 5 | ABUSARBUTUS BIOPHARMA CORPhistory → | COM | 3.64% | $2M | 682.5K |
| 6 | EVLVEVOLV TECHNOLOGIES HLDNGS INhistory → | COM CL A | 2.28% | $1M | 353.0K |
| 7 | NVTSNAVITAS SEMICONDUCTOR CORPhistory → | COM | 1.26% | $772,959 | 216.5K |
| 8 | ACHR/WSARCHER AVIATION INChistory → | *W EXP 09/16/202 | 1.07% | $657,509 | 204.2K |
| 9 | ROIVROIVANT SCIENCES LTD | SHS | 0.90% | $551,763 | 46.6K |
| 10 | ALPHA TAU MEDICAL LTD | *W EXP 99/99/999 | 0.33% | $201,701 | 960.5K |
| 11 | DAVEWDAVE INC | *W EXP 01/05/202 | 0.25% | $154,769 | 966.7K |
| 12 | WHEELER REAL ESTATE INVT TR | CV PFD SER B | 0.25% | $152,500 | 50.0K |
| 13 | REZOLVE AI LTD | *W EXP 08/15/202 | 0.17% | $102,383 | 139.1K |
| 14 | HTZHERTZ GLOBAL HLDGS INC | COM NEW | 0.15% | $91,500 | 25.0K |
| 15 | TEVOGEN BIO HLDGS INC | *W EXP 02/14/202 | 0.10% | $62,640 | 1.16M |
| 16 | NIOBWNIOCORP DEVS LTD | *W EXP 03/17/202 | 0.08% | $46,313 | 498.0K |
| 17 | LMND/WSLEMONADE INC | *W EXP 02/09/202 | 0.03% | $19,780 | 145.3K |
| 18 | SATIXFY COMMUNICATIONS LTD | ORD SHS | 0.03% | $17,910 | 11.7K |
| 19 | WAG GROUP CO | *W EXP 07/30/202 | 0.02% | $12,573 | 990.0K |
| 20 | HERAMBA ELEC PLC | *W EXP 07/26/202 | 0.02% | $10,568 | 247.5K |
| 21 | FOXO TECHNOLOGIES INC | CL A NEW | 0.01% | $8,005 | 27.5K |
| 22 | BYNOWBYNORDIC ACQUISITION CORP | *W EXP 07/01/202 | 0.01% | $4,242 | 139.1K |
| 23 | MARBLEGATE ACQUISITION CORP | *W EXP 08/31/202 | 0.01% | $4,130 | 137.7K |
| 24 | PAGAYA TECHNOLOGIES LTD | *W EXP 99/99/999 | 0.01% | $3,956 | 65.4K |
| 25 | ZAPP ELEC VEHS GROUP LTD | *W EXP 99/99/999 | 0.01% | $3,071 | 404.1K |
| 26 | BNAIWBRAND ENGAGEMENT NETWORK INC | *W EXP 03/14/202 | 0.00% | $2,759 | 49.4K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2024 | $61M | 27 | Feb 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $79M | 32 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $52M | 38 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $59M | 46 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $24M | 44 | Feb 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $68M | 54 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $118M | 71 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $180M | 83 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $329M | 101 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $403M | 118 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $441M | 125 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $585M | 128 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $582M | 119 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $515M | 97 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $483M | 83 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $424M | 59 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $136M | 25 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- GRATIA CAPITAL, LLC28-15971
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.